I'm very interested in it for the stroke/TBI indication. Once again very impressive research into that field of neuroprotection and repair. I guess one day we'll get the funds to develop a pipeline for some of these indications. I've seen some research into PD before but first time I've heard them mention that. I'm more interested in MS over the long haul to be honest. What bryostatin accomplished in the MS mouse model was something no other approved drug has ever shown in that model.
Exactly what I was thinking if we had improvement across the board even if there was a misdiagnosed patient in the group it apparently worked on whatever they had too.
News 
Market Data 
Discover 
